These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibiting Rev-erbα-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes. Huang Q; Tian H; Tian L; Zhao X; Li L; Zhang Y; Qiu Z; Lei S; Xia Z Free Radic Biol Med; 2023 Nov; 209(Pt 1):135-150. PubMed ID: 37805047 [TBL] [Abstract][Full Text] [Related]
3. 6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway. Wu S; Zhu J; Wu G; Hu Z; Ying P; Bao Z; Ding Z; Tan X Oxid Med Cell Longev; 2022; 2022():3027514. PubMed ID: 36624878 [TBL] [Abstract][Full Text] [Related]
4. Roles of HDAC3-orchestrated circadian clock gene oscillations in diabetic rats following myocardial ischaemia/reperfusion injury. Qiu Z; Ming H; Lei S; Zhou B; Zhao B; Yu Y; Xue R; Xia Z Cell Death Dis; 2021 Jan; 12(1):43. PubMed ID: 33414413 [TBL] [Abstract][Full Text] [Related]
5. Dietary capsaicin attenuates cardiac injury after myocardial infarction in type 2 diabetic mice by inhibiting ferroptosis through activation of TRPV1 and Nrf2/HMOX1 pathway. Yang C; Guo W; He R; Meng X; Fu J; Lu Y Int Immunopharmacol; 2024 Oct; 140():112852. PubMed ID: 39106715 [TBL] [Abstract][Full Text] [Related]
6. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852 [TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway. Li F; Hu Z; Huang Y; Zhan H J Cardiothorac Surg; 2023 Jul; 18(1):223. PubMed ID: 37430319 [TBL] [Abstract][Full Text] [Related]
8. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress. Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202 [TBL] [Abstract][Full Text] [Related]
9. Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis. Tian H; Xiong Y; Zhang Y; Leng Y; Tao J; Li L; Qiu Z; Xia Z Cell Stress Chaperones; 2021 Mar; 27(2):149-164. PubMed ID: 35124772 [TBL] [Abstract][Full Text] [Related]
10. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats. Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function. Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979 [TBL] [Abstract][Full Text] [Related]
12. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress. Chen X; Qian J; Wang L; Li J; Zhao Y; Han J; Khan Z; Chen X; Wang J; Liang G Endocrine; 2018 Apr; 60(1):83-94. PubMed ID: 29392616 [TBL] [Abstract][Full Text] [Related]
13. Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy. Li H; Shi Y; Wang X; Li P; Zhang S; Wu T; Yan Y; Zhan Y; Ren Y; Rong X; Xia T; Chu M; Wu R Chem Biol Interact; 2019 Sep; 310():108754. PubMed ID: 31323227 [TBL] [Abstract][Full Text] [Related]
14. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress. Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951 [TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36-mediated ferroptosis. Li X; Li Z; Dong X; Wu Y; Li B; Kuang B; Chen G; Zhang L Phytother Res; 2023 Jul; 37(7):3042-3056. PubMed ID: 36882189 [TBL] [Abstract][Full Text] [Related]
16. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy. Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083 [TBL] [Abstract][Full Text] [Related]
18. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Du S; Shi H; Xiong L; Wang P; Shi Y Front Endocrinol (Lausanne); 2022; 13():1011669. PubMed ID: 36313744 [TBL] [Abstract][Full Text] [Related]
19. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress. You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811 [TBL] [Abstract][Full Text] [Related]